Ocugen, Inc. Files 8-K Reporting Other Events
Ticker: OCGN · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, reporting, regulatory
Related Tickers: OCGN
TL;DR
OCGN filed an 8-K on 3/3/25, standard reporting update, no major news yet.
AI Summary
Ocugen, Inc. filed an 8-K on March 3, 2025, reporting other events and financial statements. The filing does not contain specific details about new material events or financial figures within the provided text, but indicates a standard reporting update.
Why It Matters
This 8-K filing serves as a notification to investors and the public about significant events or financial updates from Ocugen, Inc. It is crucial for understanding the company's ongoing operations and compliance.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing notification and does not contain any specific material events, financial disclosures, or forward-looking statements that would indicate a change in risk.
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- March 3, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Malvern, Pennsylvania (location) — Business Address
FAQ
What is the primary purpose of this 8-K filing for Ocugen, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 3, 2025.
What is Ocugen, Inc.'s Central Index Key (CIK)?
Ocugen, Inc.'s Central Index Key (CIK) is 0001372299.
When was Ocugen, Inc. incorporated?
Ocugen, Inc. was incorporated in Delaware.
What is the business address and phone number for Ocugen, Inc.?
The business address is 11 Great Valley Parkway, Malvern, Pennsylvania 19355, and the telephone number is 484-328-4701.
What is the SIC code for Ocugen, Inc.?
The Standard Industrial Classification (SIC) code for Ocugen, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding Ocugen, Inc. (OCGN).